Supreme Court Questions Centre on Medicine Pricing and Calls for Stricter Controls
The Supreme Court on October 27, 2026, questioned the Centre over steep mark-ups on medicines, highlighting a wide gap between maximum retail prices (MRP) and retailer costs. The court criticized the National Pharmaceutical Pricing Authority (NPPA) as ineffective and challenged the government's policy of limited price control, especially on anti-cancer drugs. It condemned high hospital charges and called for stricter regulation to protect patients from excessive costs, emphasizing that economic policy should not override citizens' health needs. The court reserved its verdict on petitions seeking tighter price controls and reforms.
First-hand measurement across 15 sources
We measured how 15 outlets covered this story. Coverage leans balanced overall (Left 26%, Centre 74%, Right 0%). Overall sentiment is negative (30/100). Lens Score 63/100.
Outlets measured: thetribune, economictimes, thestatesman, news18, thehindu, businessstandard, deccanherald, mint, and 7 more. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 3 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (28–38/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
hindustantimes broke this story on 27 Oct, 10:36 am. Other outlets followed.